State: | California |
---|---|
Address: | 601 Gateway Blvd #1270, South San Francisco, CA 94080, USA |
Postal code: | 94080 |
Phone: | (650) 866-8065 |
Website: | http://nvtpharma.com/ |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Nuvelution Pharma, Inc., use the form below and your opinion, advice or comment will appear in this space.
Nuvelution Pharma, Inc. 101 Main Street, Suite 1210 Cambridge, MA 02142 Phone : (650) 866
Jerusalem and San Francisco, CA, September 19, 2017 - Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Nuvelution Pharma, Inc. today announced their partnership to develop AUSTEDO® (deutetrabenazine) tablets for the treatment of tics associated with Tourette syndrome (TS) in pediatric patients in the United States.
View Joseph Poirier's business profile and see work history, affiliations and more.
Wrong Betsy Garofalo? Update Profile. Betsy Garofalo Expert CNS Consultant at Nuvelution Pharma Inc. Wrong Betsy Garofalo? Update Profile. ... (650) 866-8065. Email:
Teva Pharmaceutical Industries Ltd. and Nuvelution Pharma, Inc. today announced their partnership to develop AUSTEDO® (deutetrabenazine) tablets for the treatment of tics associated with Tourette syndrome (TS) in pediatric patients in the United States.
Nuvelution Pharma, Inc., today announced that Kirk Ways M.D., Ph.D., has been named Chief Medical Officer effective immediately. Dr. Ways is a seasone
SAN FRANCISCO--(BUSINESS WIRE)-- Nuvelution Pharma, Inc. today announced the initiation of patient enrollment in the Phase II/III ... (650) 866-8065 United States
Nuvelution Pharma Inc. Phone: (650) 866-8065 601 Gateway Boulevard Suite 1270 South San Francisco, CA 94080 USA Advertisement You must sign in to use this functionality
Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) and Nuvelution Pharma, Inc. today announced their partnership to develop AUSTEDO® (deutetrabe ... Sandy Zweifach, 650-866-8065 ...